UGT1A1*6 AND Irinotecan response
- Germline classification:
- drug response (1 submission)
- Last evaluated:
- Apr 4, 2018
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000664403.10
Allele description [Variation Report for UGT1A1*6]
UGT1A1*6
Condition(s)
- Name:
- Irinotecan response
- Synonyms:
- Camptosar response
- Identifiers:
- MedGen: CN077989
Assertion and evidence details
Last Updated: Nov 3, 2024